These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1275155)

  • 41. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A
    J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of synthetic progestins with a varying dose of estrogen on the functional state of the liver in dysfunctional uterine hemorrhages].
    Rotkina IE; Lutsik LA; Sinel'nikova AD
    Akush Ginekol (Mosk); 1979 Oct; (10):31-4. PubMed ID: 507333
    [No Abstract]   [Full Text] [Related]  

  • 43. [The use of the Norcolut preparation in gynecologic; practice].
    Bozhinova S
    Akush Ginekol (Sofiia); 1996; 35(3):50-1. PubMed ID: 9045566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Course of pregnancy and labor in women following stimulation of the ovulation with clomiphene and synthetic progestins].
    Manuilova IA; Ivanov IP; Pshenichnikova TIa; Fuks MA; Demidova TV
    Akush Ginekol (Mosk); 1977 Nov; (11):13-6. PubMed ID: 605953
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of synthetic progestins on carbohydrate metabolism and the content of anti-insulin hormones].
    Serebrennikova KG; Shinkareva LF
    Akush Ginekol (Mosk); 1980 Oct; (10):41-2. PubMed ID: 6255812
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical aspects and diagnosis of climacteric cardiopathy].
    Vdovenko LG; Asunina AD
    Kardiologiia; 1978 May; 18(5):136-8. PubMed ID: 671982
    [No Abstract]   [Full Text] [Related]  

  • 47. [Climacteric cardiopathy in women].
    Tomov L; Pelov R; Turnovska R
    Vutr Boles; 1979; 18(3):141-7. PubMed ID: 383114
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hormone substitution in climacteric. Position of the German Menopause Society].
    Schneider HP; Kuhl H; Dören M; Hesch D
    Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352
    [No Abstract]   [Full Text] [Related]  

  • 49. [Are progestational agents indicated in threatened abortion?].
    Ned Tijdschr Geneeskd; 1975 Nov; 119(48):1904-5. PubMed ID: 1214899
    [No Abstract]   [Full Text] [Related]  

  • 50. [Climacteric cardiopathy].
    Kretova NE
    Klin Med (Mosk); 1978 Oct; 56(10):40-4. PubMed ID: 713457
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristics of progestin use in pre-menopausal women].
    Khomasuridze AG; Liakhov AD
    Akush Ginekol (Mosk); 1982 Oct; (10):36-9. PubMed ID: 7180997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [On the problem of climacteric cardiodystrophy].
    Vorob'ev AI; Shishkova TV
    Ter Arkh; 1967 Mar; 39(3):90-6. PubMed ID: 5616785
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)].
    Hauser GA; Ernst U
    Zentralbl Gynakol; 1999; 121(11):530-6. PubMed ID: 10612221
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
    Africander D; Verhoog N; Hapgood JP
    Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Characteristics of the reproductive function in genital endometriosis before and after the use of synthetic progestins].
    Shinkareva LF; Nagovitsyna AI; Sabsaĭ MI; Serebrennikova KG
    Vopr Okhr Materin Det; 1977 Dec; 22(12):60-5. PubMed ID: 341510
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hormone treatment of sex disorders in menopause--causal therapy or placebo?].
    Loewit K
    Geburtshilfe Frauenheilkd; 1993 Nov; 53(11):814-8. PubMed ID: 8293950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A; Fedele M; Renzetti ME; Ferraris G
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract]   [Full Text] [Related]  

  • 59. [Climacteric--from the viewpoint of the established gynecologist. Interview by Jeanette Gerhardt].
    Gericke DS
    Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):IX-X. PubMed ID: 8150240
    [No Abstract]   [Full Text] [Related]  

  • 60. Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
    Sobel NB
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):299-319. PubMed ID: 7936546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.